Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data

Abstract

Objective

The optimal modification of retinopathy of prematurity (ROP) screening policy in our unit, by tightening the applicable screening criteria, without missing treatment-requiring ROP (TR-ROP).

Study design

Retrospective analysis of screened infants with gestational age (GA) < 32 weeks and/or birth weight (BW) < 1501 g as well as cases beyond these thresholds but with comorbidities (April 2004 to April 2020).

Result

Of 1560 included infants, 18.4% (n = 288) developed any stage of ROP and 3.1% (n = 49) were treated. TR-ROP occurred at a mean (SD) 362/7 (25/7) weeks PMA, and not before a minimum of 323/7 weeks PMA. No treated infant would have been missed if screening criteria were reduced to GA < 30 weeks and/or BW < 1251 g. This modification would have resulted in 826 (52.9%) fewer infants undergoing screening.

Conclusion

Modifying the current screening criteria to GA < 30 weeks and/or BW < 1251 g would have spared over half of the screened infants from unnecessary examinations, without missing TR-ROP.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flowchart of preterm infants included in the analysis.
Fig. 2: Linear regression analysis for change in gestational age (GA) and birth weight (BW) of screened infants over time.

Similar content being viewed by others

References

  1. Martin JA, Osterman MJK. Describing the increase in preterm births in the United States, 2014-2016. NCHS Data Brief. 2018:1–8.

  2. Baroutis G, Mousiolis A, Mesogitis S, Costalos C, Antsaklis A. Preterm birth trends in Greece, 1980-2008: a rising concern. Acta Obstet Gynecol Scand. 2013;92:575–82.

    Article  Google Scholar 

  3. Vlachadis N, Kornarou E, Ktenas E. The preterm births epidemic in Greece. Acta Obstet Gynecol Scand. 2013;92:1231.

    PubMed  Google Scholar 

  4. Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74 Suppl 1:35–49.

    Article  Google Scholar 

  5. Pivodic A, Hård AL, Löfqvist C, Smith LEH, Wu C, Bründer MC, et al. Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics. JAMA Ophthalmol. 2020;138:21–29.

    Article  Google Scholar 

  6. Van Sorge AJ, Schalij-Delfos NE, Kerkhoff FT, Van Rijn LJ, van Hillegersberg JL, van Liempt IL, et al. Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria. Br J Ophthalmol. 2013;97:1143–7.

    Article  Google Scholar 

  7. Adams GGW, Williams C, Modi N, Xing W, Bunce C, Dahlmann-Noor A. Can we reduce the burden of the current UK guidelines for retinopathy of prematurity screening? Eye (Basingstoke). 2018;32:235–7.

    CAS  Google Scholar 

  8. Mataftsi A, Moutzouri S, Karagianni P, Ziakas N, Soubasi V, Brazitikos P, et al. Retinopathy of prematurity occurrence and evaluation of screening policy in a large tertiary Greek cohort. Int Ophthalmol. 2020;40:385–91. https://doi.org/10.1007/s10792-019-01195-5.

  9. Royal College of Ophthalmologists, Royal College of Paediatrics and Child Health. Guideline for the screening and treatment of retinopathy of prematurity. UK retinopathy of prematurity guideline. 2008. https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2008-SCI-021-Guidelines-Retinopathy-of-Prematurity.pdf. Accessed 3 Jun 2017.

  10. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991;98:1628–40.

    Article  CAS  Google Scholar 

  11. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–94.

    Article  Google Scholar 

  12. R Core Team. R: a language and environment for statistical computing. 2020.

  13. Saugstad OD. Oxygenation of the immature infant: a commentary and recommendations for oxygen saturation targets and alarm limits. Neonatology. 2018;114:69–75.

    Article  CAS  Google Scholar 

  14. Holmström G, Hellström A, Gränse L, Saric M, Sunnqvist B, Wallin A, et al. New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register. Br J Ophthalmol. 2020;104:943–9. https://doi.org/10.1136/bjophthalmol-2019-314874.

  15. Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, et al. Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018;136:1383–9.

    Article  Google Scholar 

  16. Mitchell AJ, Green A, Jeffs DA, Roberson PK. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011;11:291–7.

    Article  Google Scholar 

  17. Disher T, Cameron C, Mitra S, Cathcart K, Campbell-Yeo M. Pain-relieving interventions for retinopathy of prematurity: a meta-analysis. Pediatrics. 2018;142:1–12.

    Article  Google Scholar 

  18. Belda S, Pallás CR, De La Cruz J, Tejada P. Screening for retinopathy of prematurity: is it painful? Biol Neonate. 2004;86:195–200.

    Article  Google Scholar 

  19. Trzcionkowska K, Vehmeijer WBHJ, Kerkhoff FT, Bauer NJC, Bennebroek CAM, Dijk PH, et al. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017. Acta Ophthalmol. 2021;99:97–103.

  20. Yang Q, Zhou X, Ni Y, Shan H, Shi W, Yin X, et al. Optimised retinopathy of prematurity screening guideline in China based on a 5-year cohort study. Br J Ophthalmol. 2021;105:819–23.

  21. Pivodic A, Hård AL, Löfqvist C, Smith LEH, Wu C, Bründer MC, et al. Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics. JAMA Ophthalmol. 2020;138:21–29.

    Article  Google Scholar 

  22. Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142:e20183061. https://doi.org/10.1542/peds.2018-3061.

  23. Jefferies A, Canadian Paediatric Society, Fetus and Newborn Committee. Retinopathy of prematurity: an update on screening and management. Paediatr Child Health. 2016;21:101–04.

    Article  Google Scholar 

  24. Fledelius HC, Rosenberg T. Retinopathy of prematurity. where to set screening limits? Acta Pediatr Scand. 1990;79:906–10.

    Article  CAS  Google Scholar 

  25. Jandeck C. Guidelines for ophthalmological screening of premature born neonates. Ophthalmologe. 2008;105:81–6, 88–90. https://doi.org/10.1007/s00347-007-1674-y.

  26. Dai S, Austin N, Darlow B. Retinopathy of prematurity: New Zealand recommendations for case detection and treatment. J Paediatr Child Health. 2015;51:955–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors took part in the design of the study. SM, AM, AKS, and A-BH wrote the manuscript and the remaining authors gave their feedback and modifications. Statistical analysis was performed by SM and A-BH. All authors reviewed the results and approved the final version of the manuscript.

Corresponding author

Correspondence to Asimina Mataftsi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moutzouri, S., Haidich, AB., Seliniotaki, A.K. et al. Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data. J Perinatol 42, 365–370 (2022). https://doi.org/10.1038/s41372-021-01196-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-021-01196-2

Search

Quick links